MOPEAD newsletter 01

Alzheimer Europe organised a Symposium supported by Eli Lilly on 4 October 2017 at its annual conference in Berlin.

The symposium titled “Engaging with Patient Organizations within the IMI Consortia to inform quality, relevance and value in Alzheimer’s res...

Discussions took place on Pre-screening Initiatives to Identify Individuals with Preclinical or Early Alzheimer’s disease for Clinical Trials.

On 21 October, David Krivec (Secretary General at Spominčica - Alzheimer Slovenija) will be presenting the MOPEAD project at their 9th Alzheimer Slovenia Conference (ASK 2017) during the celebration of the 20th anniversary of the association. The Conferenc...

We are excited to announce that the next occasion to meet the MOPEAD team is at the 27th Alzheimer Europe Conference, being held in Berlin from 2-4 October. MOPEAD will be represented on 4 October, at a symposium convened by Eli Lilly, entitled: “Engaging...

The MOPEAD Consortium met for the third time on 15 July 2017 in London. The AAIC17 conference was an opportunity to gather all project partners present at the conference.

An update on each of the patient recruitment processes was given (especially around th...

On 13 July, the communication team of the MOPEAD project released their first infographic. It emphasises general information on the Models of Patient Engagement for Alzheimer’s disease, giving an overview of the project’s background, motivation and objecti...

During Brain Awareness Week, organised by SINAPSA - Slovenian Neuroscience Association, Dr. Milica Gregorič Kramberger presented the MOPEAD project, methods of patients engagement and importance of early diagnosis from the perspective of research and clini...

The MOPEAD Consortium met for the second time on 16-17 March 2017 in Brussels. The aim of the meeting was for each Workpackage leader to give an update on the progress, issues, challenges and next actions of their respective Workpackage.

On the 14th and 15th December the consortium met in Barcelona to officially launch the project. Representatives from all fourteen partners met at the headquarters of Fundació ACE in order to develop initial project processes, plan and begin work in the ear...

Novel Research to improve timely diagnosis of Alzheimer’s disease (AD) through citizen participation. Today, a significant proportion of people with dementia are not diagnosed and, consequently, do not have access to available care and treatment. This also...

Please reload

Please reload

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations